Presented at Molecular Medicine Tri-Conference 2017, this presentation provides insights into how flow cytometry data analysis can be more precise, reliable, and valuable. With an exponential growth in personalized medicine and in particular immuno-oncology, flow cytometry has become a key tool for drug developers.

Download this presentation to learn more about how Q² Solutions is helping its customers effectively utilize flow cytometry services by offering the largest global footprint for flow cytometry services, innovative technology that provides high quality data with minimal variability, and continuous improvement efficiency initiatives to meet customers' individual needs.

Author:
Mark Edinger, Scientific Advisor, Flow Cytometry